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ABSTRACT
Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) 
for severe aortic stenosis (AS) is a minimally invasive interventional procedure that repairs a 
valve without removing the old, damaged valve. Instead, a replacement valve is wedged into the 
location of the native aortic valve. During TAVR, contrast is used for conventional aortic root 
angiography, positioning of the TAVR valve device, and assessing the peripheral vasculature. 
Therefore, contrast-induced acute kidney injury (AKI) is a major concern when performing TAVR 
and is associated with increased mortality in patients with impaired renal function. Although the 
exact mechanism of post-TAVR AKI is unknown and appears multifactorial, contrast medium has 
been reported as a major contributing factor. We report a case of zero-contrast TAVR for severe 
AS in a patient with chronic kidney disease (CKD). The procedure was successfully performed 
with only fluoroscopic and transesophageal echocardiography (TEE) guidance.
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INTRODUCTION
Transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation 
(TAVI) for severe aortic stenosis (AS) is the minimally invasive interventional procedure that 
repair valve without removing the old, damaged valve. Instead, it wedges a replacement into 
the place of native aortic valve.1
During TAVR, contrast is used for conventional aortic root angiography, positioning of the 
TAVR valve device and assessing the peripheral vasculature. Therefore, contrast induced 
acute kidney injury (AKI) is one of the major concerns of TAVR and is associated with 
increased mortality in patients with impaired renal function. Although the exact mechanism 
of post-TAVR AKI is unknown and seems to be multifactorial, however, contrast medium 
itself has been reported as a major contributing factor.2
We report a case of zero-contrast usage for TAVR for severe AS in patient with chronic kidney 
disease (CKD). This procedure was performed successfully in this case with only fluoroscopic 
and transesophageal echocardiography (TEE) guidance.
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CASE REPORT
An 88-year-old female was admitted due to aggravating dyspnea (New York Heart Association 
functional class III). She had a history of hypertension, diabetes, CKD and persistent atrial 
fibrillation. Coronary angiography showed no significant stenotic lesion. Echocardiography 
showed normal left ventricular ejection fraction but severe AS was noted (Fig. 1). Aortic valve 
area was 0.96 cm2 on the planimetry method. Peak velocity across aortic valve was 4.2 m/s 
and mean pressure gradient were 30 mmHg. Society of Thoracic Surgeons score was 8%.
She was in CKD stage IV, blood urea nitrogen (BUN) 40.1 mg/dL, creatinine 2.9 mg/dL, 
epidermal growth factor receptor (eGFR) 14 mL/min/1.73 m2. Because of CKD, computed 
tomography (CT) angiography was not done. And she was sensitive to volume overload, so 
we did not do hydration. From the 3D echocardiographic data (Fig. 2), the mean annulus 
diameter was 24.6 mm and the perimeter was 71.2 mm. Distance from annulus to left main 
and right coronary artery ostium was 16.3 and 15.8 mm, respectively. Because of stage IV 
CKD, TAVR was planned without using contrast agent.
Under general anesthesia, temporary pacemaker was inserted through right femoral vein. 7 Fr 
sheath and 6 Fr pig-tail catheter were inserted through right femoral artery under sono-guided 
puncture technique. 8 Fr sheath was inserted through left femoral artery and replaced with 18 Fr 
Sentrant sheath. Straight coil wire under back-up with an AL 1 diagnostic catheter was crossed 
the stenotic aortic valve. Then, straight coil wire was changed to the round-shaped Amplatz stiff 
wire. Under TEE guidance, a 29-mm Evolut R prosthesis was placed at the optimal position and 
was deployed successfully (Fig. 3). After valve implantation, follow-up TEE showed mild para-
valvular leak and mild to moderate AR. AR index was 24. All procedure was finished.
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Fig. 1. Transthoracic echocardiogram showed severe AS (AVA: 0.96 cm2 by continuity equation) with peak/mean pressure gradient (64/33 mmHg). 
AS; aortic stenosis, AVA; aortic valve area, BP; blood pressure.
After procedure, her renal function had not been aggravated until she was discharged (directly 
after: BUN, 46.1 mg/dL; creatinine, 3.33 mg/dL; eGFR, 11.7 mL/min/1.73 m2 and when she was 
discharged: BUN, 46.1 mg/dL; creatinine, 3.33 mg/dL; eGFR, 13 mL/min/1.73 m2).
DISCUSSION
We have reported a case of zero-contrast TAVR for severe AS in patient with CKD. This case is 
different from previous TAVR cases in terms of usage of contrast, 3D-echo in pre-evaluation, 
TEE during intervention, peripheral US in vascular access. TAVR may be an option for 
people who are considered at intermediate or high risk of complications from surgical aortic 
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Fig. 2. Annulus dimension and perimeter derived diameter by 3-dimentional echocardiogram.
Fig. 3. Location of catheter was identified by using biplane TEE (dotted circle indicated tip of catheter and 
asterisk indicated catheter). 
TEE; transesophageal echocardiography, PAT; patient, T; temperature.
valve replacement. AKI remains a major concern in the field of TAVR and is associated with 
increased mortality, up to twofold to eightfold.3
AKI in TAVR patients is most likely a combination of prerenal azotemia and direct 
nephrotoxic influences leading to renal ischemia and acute tubular necrosis (ATN). Causes 
of prerenal azotemia include (among others) hypovolemia, hemorrhage, impaired cardiac 
output or renal vasoconstriction caused by vasoconstrictive medication. The normal response 
of the kidney to prerenal conditions is to concentrate the urine and reabsorb sodium in order 
to maintain or increase intravascular volume and normalize renal perfusion. Therapy to 
restore renal perfusion promptly improves renal function. However, prolonged or profound 
prerenal azotemia can result in ischemic damage leading to ischemic AKI, particularly in 
combination with the presence of exogenous toxic compounds (e.g., aminoglycosides, 
contrast media).
So, AKI after TAVR can be considered as the common final path resulting from prerenal 
azotemia due to pre-, intra- and post-operative factors and additional nephrotoxic influences 
resulting in ATN.4-6
We particularly performed a femoral puncture by vascular ultrasound (Fig. 4). Furthermore, we 
used a 3D-echo in pre-evaluation and TEE during TAVR differently from the other cases (Fig. 5).7
Kidney function is a powerful long-term predictor of mortality in patients undergoing TAVR. 
Patients with severe impaired renal function had the highest mortality after TAVR. Thus, the 
beneficial effects of TAVR in patients with severe impaired renal function seem to be limited 
and should be implemented in a decision-making process before TAVR.8-10
All the while, it has been important to do pre-procedural assessments using multimodality 
imaging including CT angiography and conventional angiography. So, CT angiography and 
conventional angiography has been thought essential. But, we could overcome this aspect by 
using 3D-echo in pre-evaluation.
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Fig. 4. Vascular ultrasound showed acceptable access site of left external iliac artery. 
CFA; common femoral artery, SFA; superficial femoral artery, DFA; deep femoral artery.
And we have to pay the particular attention to do pre-procedural assessments by using 
3D-echo to avoid the increment of complication or failure.
Furthermore, we used TEE during the procedure, TEE-TAVR was associated with similar and 
midterm results as angiography guiding TAVR and significantly reduced contrast media use 
during the procedures.11
In conclusion, this is the case report of zero contrast with TEE guidance. The zero contrast 
TAVR is more effective method in CKD patients in avoidance of AKI.
REFERENCES
 1. Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, et al. 2017 ACC expert consensus 
decision pathway for transcatheter aortic valve replacement in the management of adults with aortic 
stenosis: a report of the American College of Cardiology Task Force on clinical expert consensus 
documents. J Am Coll Cardiol 2017;69:1313-1346. 
PUBMED | CROSSREF
66https://doi.org/10.12997/jla.2018.7.1.62
Zero-contrast TAVR for Severe AS in Patient with CKD
Fig. 5. 3D-echo in pre-evaluation and TEE during TAVR. 
TEE; transesophageal echocardiography, TAVR; transcatheter aortic valve replacement, Comm; commissure.
 2. Eskandari M, Aldalati O, Byrne J, Dworakowski R, Wendler O, Alcock E, et al. Zero contrast transfemoral 
transcatheter aortic valve replacement using fluoroscopy-echocardiography fusion imaging. Am J Cardiol 
2016;117:1861-1862. 
PUBMED | CROSSREF
 3. Cheungpasitporn W, Thongprayoon C, Kashani K. Transcatheter aortic valve replacement: a kidney's 
perspective. J Renal Inj Prev 2016;5:1-7. 
PUBMED | CROSSREF
 4. Fassa AA, Himbert D, Vahanian A. Mechanisms and management of TAVR-related complications. Nat Rev 
Cardiol 2013;10:685-695. 
PUBMED | CROSSREF
 5. Scherner M, Wahlers T. Acute kidney injury after transcatheter aortic valve implantation. J Thorac Dis 
2015;7:1527-1535.
PUBMED
 6. Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P, Kittanamongkolchai W, Greason KL, et al. 
Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. 
Am J Nephrol 2015;41:372-382. 
PUBMED | CROSSREF
 7. Varga-Szemes A, Cannao PM, Muscogiuri G, De Cecco CN, Giri S, Piccini D, et al. Non-contrast 3D 
radial and QISS MRA for transcatheter aortic valve replacement planning. J Cardiovasc Magn Reson 
2015;17:O71. 
CROSSREF
 8. Voigtländer L, Schewel J, Martin J, Schewel D, Frerker C, Wohlmuth P, et al. Impact of kidney function 
on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J 
Cardiol 2015;178:275-281. 
PUBMED | CROSSREF
 9. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochellière R, Doyle D, et al. Acute kidney injury 
following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison 
with surgical aortic valve replacement. Eur Heart J 2010;31:865-874. 
PUBMED | CROSSREF
 10. Barbash IM, Ben-Dor I, Dvir D, Maluenda G, Xue Z, Torguson R, et al. Incidence and predictors of acute 
kidney injury after transcatheter aortic valve replacement. Am Heart J 2012;163:1031-1036. 
PUBMED | CROSSREF
 11. Bagur R, Rodés-Cabau J, Doyle D, De Larochellière R, Villeneuve J, Lemieux J, et al. Usefulness of TEE 
as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC 
Cardiovasc Imaging 2011;4:115-124. 
PUBMED | CROSSREF
67https://doi.org/10.12997/jla.2018.7.1.62
Zero-contrast TAVR for Severe AS in Patient with CKD
